ColomboC, VergaU, MianC, FerreroS, PerrinoM, VicentiniL, DazziD, OpocherG, PelizzoMR, Beck-PeccozP, FugazzolaL. 2012. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab, 97:905–913.
2.
EliseiR, AlevizakiM, Conte-DevolxB, Frank-RaueK, LeiteV, WilliamsGR. 2012. European Thyroid Association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. Eur Thyroid J, 1:216–231.
3.
DoyleP, DürenC, NerlichK, VerburgFA, GrelleI, JahnH, FassnachtM, MäderU, ReinersC, LusterM. 2009. Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab, 94:2970–2974.
4.
DruckerD. Atrial fibrillation after administration of calcium and pentagastrin. 1981. N Engl J Med, 304:1427–1428.
5.
PoonuruS, RoseBG. 2012. Dramatic elevation of serum calcitonin levels with calcium loading test in C-cell hyperplasia. Endocr Rev, 33:MON391 (abstract).
6.
Calcium gluconate, ISDB WHO Single Medicines Review, 2004. Available at: http://archives.who.int/eml/expcom/expcom14/calcium_gluconate/calciumgluconate_ISDB_review.pdf (accessed August7, 2013).
7.
KloosRT, EngC, EvansDB, FrancisGL, GagelRF, GharibH, MoleyJF, PaciniF, RingelMD, SchlumbergerM, WellsSAJr. 2009. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid, 19:565–612.
